RETRACTION: Nesfatin-1/Nucleobindin-2 Is a Potent Prognostic Marker and Enhances Cell Proliferation, Migration, and Invasion in Bladder Cancer

Disease Markers. Dis Markers. 2025.

. 2025 Apr 26:2025:9803765.

doi: 10.1155/dim/9803765. eCollection 2025.

Abstract

[This retracts the article DOI: 10.1155/2018/4272064.].

Nesfatin-1/Nucleobindin-2 Is a Potent Prognostic Marker and Enhances Cell Proliferation, Migration, and Invasion in Bladder Cancer.
Liu GM, Xu ZQ, Ma HS. Liu GM, et al. Dis Markers. 2018 Sep 19;2018:4272064. doi: 10.1155/2018/4272064. eCollection 2018. Dis Markers. 2018. Retraction in: Dis Markers. 2025 Apr 26;2025:9803765. doi: 10.1155/dim/9803765. PMID: 30327690 Free PMC article. Retracted.

1. Hoya camphorifolia. Nesfatin-1/Nucleobindin-2 Is a Potent Prognostic Marker and Enhances Cell Proliferation, Migration, and Invasion in Bladder Cancer. PubPeer . April 2023, https://pubpeer.com/publications/15CD48F233764354BAB0A29D2C5F71.
1. Li G., Xie Z.-K., Zhu D.-S., Guo T., Cai Q.-L., Wang Y. KIF20B Promotes the Progression of Clear Cell Renal Cell Carcinoma by Stimulating Cell Proliferation. Journal of Cellular Physiology . 2019;234(9):16517–16525. doi: 10.1002/jcp.28322. - DOI - PubMed
1. Chen J., Zhao C.-C., Chen F.-R., Feng G.-W., Luo F., Jiang T. KIF20B Promotes Cell Proliferation and May Be a Potential Therapeutic Target in Pancreatic Cancer. Journal of Oncology . 2021;2021:1–11. doi: 10.1155/2021/5572402. - DOI - PMC - PubMed
1. Liu Z.-H., Dong S.-X., Jia J.-H., Zhang Z.-L., Zhen Z.-G. KIF3B Promotes the Proliferation of Pancreatic Cancer. Cancer Biotherapy & Radiopharmaceuticals . 2019;34(6):355–361. doi: 10.1089/cbr.2018.2716. - DOI - PubMed
1. Zhang X.-G., Zhang T., Li C.-Y., Zhang M.-H., Chen F.-M. CD164 Promotes Tumor Progression and Predicts the Poor Prognosis of Bladder Cancer. Cancer Medicine . 2018;7(8):3763–3772. doi: 10.1002/cam4.1607. - DOI - PMC - PubMed